StonvexLoading…
StonvexStonvexStonvexCore line items from RS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-07-22 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $4.35B | $4.03B | $14.29B | $10.80B | $7.14B |
Operating Income | Not available | $367.90M | $1.01B | $846.40M | $586.60M |
Net Income | Not available | $264.90M | $739.40M | $622.90M | $434.70M |
EPS (Diluted) | $5.51 | $5.10 | $13.98 | $11.74 | $8.15 |
Total Assets | Not available | $10.81B | $10.37B | $10.55B | $10.49B |
Total Liabilities | Not available | $3.68B | $3.19B | $3.23B | $3.25B |
Cash & Equivalents | Not available | $249.70M | $216.60M | $261.20M | $239.50M |
Free Cash Flow OCF − CapEx | Not available | $87.20M | $502.50M | $299.60M | $119.00M |
Shares Outstanding | Not available | 51.05M | 51.73M | 52.38M | 52.59M |